Ahmet Gül

19.6k total citations · 1 hit paper
288 papers, 7.8k citations indexed

About

Ahmet Gül is a scholar working on Rheumatology, Molecular Biology and Ophthalmology. According to data from OpenAlex, Ahmet Gül has authored 288 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Rheumatology, 81 papers in Molecular Biology and 75 papers in Ophthalmology. Recurrent topics in Ahmet Gül's work include Ocular Diseases and Behçet’s Syndrome (74 papers), Systemic Lupus Erythematosus Research (71 papers) and Inflammasome and immune disorders (60 papers). Ahmet Gül is often cited by papers focused on Ocular Diseases and Behçet’s Syndrome (74 papers), Systemic Lupus Erythematosus Research (71 papers) and Inflammasome and immune disorders (60 papers). Ahmet Gül collaborates with scholars based in Türkiye, United States and United Kingdom. Ahmet Gül's co-authors include Murat İnanç, Sevil Kamalı, İlknur Tuğal-Tutkun, Meral Koniçe, Orhan Aral, Yavuz Ceylan, Seza Özen, Meri Urgancıoğlu, Lale Öçal and Halıl Aslan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The FASEB Journal.

In The Last Decade

Ahmet Gül

261 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

EULAR recommendations for the management of Behçet disease

2008 449 citations Gülen Hatemi, Ahmet Gül et al. Annals of the Rheumatic Diseases profile →

Peers

Countries citing papers authored by Ahmet Gül

Since Specialization

Citations

This map shows the geographic impact of Ahmet Gül's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmet Gül with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmet Gül more than expected).

Fields of papers citing papers by Ahmet Gül

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmet Gül. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmet Gül. The network helps show where Ahmet Gül may publish in the future.

Co-authorship network of co-authors of Ahmet Gül

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmet Gül. A scholar is included among the top collaborators of Ahmet Gül based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmet Gül. Ahmet Gül is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NETs in the spotlight: exploring NETosis markers for tracking disease activity in IgA vasculitis 2025 ·Lara D. Veeken ·(unknown), (unknown), (unknown), (unknown), Zeliha Emrence, Özlem Akgün, (unknown), (unknown), Ayşe Tanatar, Neslihan Abacı, (unknown), Ahmet Gül, Nuray Aktay Ayaz	1
2	Damage accrual and predictors of mortality in ANCA-associated vasculitis: a retrospective observational study 2025 ·Rheumatology International ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Bahar Artım-Esen, Ahmet Gül, Murat İnanç	0
3	POS0740 VALIDATION OF THE PEDIATRIC BEHÇET DISEASE CRITERIA (PEDBD): A REAL LIFE CONSENSUS-BASED APPROACH 2023 ·Annals of the Rheumatic Diseases ·(unknown), (unknown), Sulaiman M. Al‐Mayouf, Paul Brogan, Luca Cantarini, Ahmet Gül, Özgür Kasapçopur, J. B. Kuemmerle‐Deschner, Seza Özen, David Saadoun, Farhad Shahram, (unknown), Nicolino Ruperto, Marco Gattorno, Isabelle Kone‐Paut	0
4	Behçet disease, familial Mediterranean fever and MEFV variations: More than just an association 2023 ·Clinical Immunology ·Emire Seyahi, Serdal Uğurlu, (unknown), Ahmet Gül	8
5	Validation of the PEDiatric Behçet’s Disease classification criteria: an evidence-based approach 2023 ·Lara D. Veeken ·(unknown), (unknown), Sulaiman M. Al‐Mayouf, Paul Brogan, Luca Cantarini, Ahmet Gül, Özgür Kasapçopur, Jasmin Kuemmerle‐Deschner, Seza Özen, David Saadoun, Farhad Shahram, Francesca Bovis, (unknown), Nicolino Ruperto, Marco Gattorno, Isabelle Kone‐Paut	3
6	5‐Fluoro/(trifluoromethoxy)‐2‐indolinone derivatives with anti‐interleukin‐1 activity 2023 ·Archiv der Pharmazie ·(unknown), (unknown), (unknown), (unknown), (unknown), Nathan A. Lack, Burak Erman, Ahmet Gül, Hakan S. Orer, Nilgün Karalı	3
7	Frequency and severity of COVID‐19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine 2022 ·Journal of Medical Virology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Murat Bolayırlı, Günay Can, Gülen Hatemi, Emire Seyahi, Huri Özdoğan, Ahmet Gül, Serdal Uğurlu	6
8	Improved sensitivity of the skin pathergy test with polysaccharide pneumococcal vaccine antigens in the diagnosis of Behçet disease 2022 ·Lara D. Veeken ·(unknown), Zeliha Emrence, (unknown), Bahar Artım-Esen, Murat İnanç, (unknown), Ahmet Gül	9
9	Real life data of secukinumab in ankylosing spondylitis and psoriatic arthritis: Analysis of 44 patients in a single center 2021 ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Bahar Artım-Esen, (unknown), Ahmet Gül, Murat İnanç	0
10	Long-term follow-up of 89 patients with giant cell arteritis: a retrospective observational study on disease characteristics, flares and organ damage 2020 ·Rheumatology International ·(unknown), (unknown), (unknown), Bahar Artım-Esen, Ahmet Gül, Lale Öçal, Murat İnanç	6
11	An Algorithm for the Diagnosis of Behçet Disease Uveitis in Adults 2020 ·Ocular Immunology and Inflammation ·İlknur Tuğal-Tutkun, Sumru Önal, Miles Stanford, Mehmet Akman, Jos W. R. Twisk, Maarten Boers, Merih Oray, Pınar Özdal, Sibel Kadayıfçılar, Radgonde Amer, Sivakumar R. Rathinam, (unknown), Moncef Khairallah, Yonca A. Akova, F. Nilüfer Yalçındağ, (unknown), Berna Başarır, Çiğdem Altan, Yılmaz Özyazgan, Ahmet Gül	37
12	Remarkable damage along with poor quality of life in Takayasu arteritis: cross-sectional results of a long-term followed-up multicentre cohort. 2017 ·PubMed ·Ahmet Omma, Burak Erer, Ömer Karadağ, Neslihan Yılmaz, Fatma Alıbaz-Öner, Fatih Yıldız, (unknown), Gezmiş Kimyon, Sedat Kiraz, Haner Di̇reskeneli̇, Eren Erken, Kenan Aksu, Ahmet Mesut Onat, Ahmet Gül, Lale Öçal, Murat İnanç, Sevil Kamalı	14
13	International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors 2017 ·Lara D. Veeken ·Taryn Youngstein, Patrycja Hoffmann, Ahmet Gül, Thirusha Lane, René M. Williams, Dorota Rowczenio, Huri Özdoğan, Serdal Uğurlu, John Ryan, (unknown), Sean Riminton, (unknown), Joachim Roesler, Norbert Blank, Jasmin Kuemmerle‐Deschner, Anna Simon, Adrian S. Woolf, Philip N. Hawkins, Helen J. Lachmann	88
14	Seroreactivity against PTEN-induced putative kinase 1 (PINK1) in Turkish patients with Behçet's disease. 2010 ·PubMed ·Burçak Vural, Ayşe Demirkan, (unknown), (unknown), Bahar Artım-Esen, Ali O. Güre, Ahmet Gül, Uğur Özbek	16
15	The Outcome of Twin Pregnancies Complicated by Single Fetal Death After 20 Weeks of Gestation 2004 ·Twin Research ·Halıl Aslan, Ahmet Gül, Altan Cebeci, İbrahim Polat, Yavuz Ceylan	15
16	The Outcome of Twin Pregnancies Complicated by Single Fetal Death After 20 Weeks of Gestation 2004 ·Twin Research ·Halıl Aslan, Ahmet Gül, Altan Cebeci, İbrahim Polat, Yavuz Ceylan	4
17	Natural History of 11 Cases of Twin-twin Transfusion Syndrome Without Intervention 2003 ·Twin Research ·Ahmet Gül, Halıl Aslan, İbrahim Polat, (unknown), Hasan Bulut, (unknown), Yavuz Ceylan	12
18	Natural History of 11 Cases of Twin–twin Transfusion Syndrome Without Intervention 2003 ·Twin Research ·Ahmet Gül, Halıl Aslan, İbrahim Polat, (unknown), Hasan Bulut, (unknown), Yavuz Ceylan	20
19	Transforming growth factor-12 polymorphism and systemic lupus erythematosus. 2002 ·PubMed ·Aliya Al-Ansari, Ali H. Hajeer, Lee Suan Teh, Ardeshir Bayat, (unknown), Ahmet Gül, Murat İnanç, José Ordi-Ros, William Ollier	3
20	Lack of association of HLA-B51 with a severe disease course in Behcet's disease 2001 ·British journal of rheumatology* ·Ahmet Gül	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact